EMBO Molecular Medicine (Sep 2024)

Mutation in the mitochondrial chaperone TRAP1 leads to autism with more severe symptoms in males

  • Małgorzata Rydzanicz,
  • Bozena Kuzniewska,
  • Marta Magnowska,
  • Tomasz Wójtowicz,
  • Aleksandra Stawikowska,
  • Anna Hojka,
  • Ewa Borsuk,
  • Ksenia Meyza,
  • Olga Gewartowska,
  • Jakub Gruchota,
  • Jacek Miłek,
  • Patrycja Wardaszka,
  • Izabela Chojnicka,
  • Ludwika Kondrakiewicz,
  • Dorota Dymkowska,
  • Alicja Puścian,
  • Ewelina Knapska,
  • Andrzej Dziembowski,
  • Rafał Płoski,
  • Magdalena Dziembowska

DOI
https://doi.org/10.1038/s44321-024-00147-6
Journal volume & issue
Vol. 16, no. 11
pp. 2976 – 3004

Abstract

Read online

Abstract There is increasing evidence of mitochondrial dysfunction in autism spectrum disorders (ASD), but the causal relationships are unclear. In an ASD patient whose identical twin was unaffected, we identified a postzygotic mosaic mutation p.Q639* in the TRAP1 gene, which encodes a mitochondrial chaperone of the HSP90 family. Additional screening of 176 unrelated ASD probands revealed an identical TRAP1 variant in a male patient who had inherited it from a healthy mother. Notably, newly generated knock-in Trap1 p.Q641* mice display ASD-related behavioral abnormalities that are more pronounced in males than in females. Accordingly, Trap1 p.Q641* mutation also resulted in sex-specific changes in synaptic plasticity, the number of presynaptic mitochondria, and mitochondrial respiration. Thus, the TRAP1 p.Q639* mutation is the first example of a monogenic ASD caused by impaired mitochondrial protein homeostasis.

Keywords